ND

Nitin Dnyandev Satpute

Active Director Director DIN 10181396
DIN 10181396 First appointment May 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Nitin Dnyandev Satpute

Data last updated:

Nitin Dnyandev Satpute is a Director at Akii Pharmaceutical Private Limited (since 2023). The company operates in Pharma.

DIN 10181396
Primary Designation Director
Industry Pharma
First Appointment 29 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Akii Pharmaceutical Private Limited U21009MH2023PTC403766
Director29 May 20232023Active

Board colleagues of Nitin Dnyandev Satpute

NameDINCompanyDesignation
Sachin Dnyandev Satpute10181395Akii Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Akii Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Nitin Dnyandev Satpute

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nitin Dnyandev Satpute

Nitin Dnyandev Satpute currently holds 1 directorship: Akii Pharmaceutical Private Limited (Director, since 29 May 2023).

Nitin Dnyandev Satpute was first appointed on 29 May 2023 as Director at Akii Pharmaceutical Private Limited.

The current boards of Nitin Dnyandev Satpute's companies include Sachin Dnyandev Satpute (Akii Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available